These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
283 related items for PubMed ID: 2072118
1. Serum creatine-kinase (CK) and pyruvate-kinase (PK) activities in Duchenne (DMD) as compared with Becker (BMD) muscular dystrophy. Zatz M, Rapaport D, Vainzof M, Passos-Bueno MR, Bortolini ER, Pavanello Rde C, Peres CA. J Neurol Sci; 1991 Apr; 102(2):190-6. PubMed ID: 2072118 [Abstract] [Full Text] [Related]
2. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis. Zatz M, Otto PA. Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019 [Abstract] [Full Text] [Related]
3. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers. Sumita DR, Vainzof M, Campiotto S, Cerqueira AM, Cánovas M, Otto PA, Passos-Bueno MR, Zatz M. Am J Med Genet; 1998 Dec 04; 80(4):356-61. PubMed ID: 9856563 [Abstract] [Full Text] [Related]
5. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection. Percy ME, Chang LS, Murphy EG, Oss I, Verellen-Dumoulin C, Thompson MW. Muscle Nerve; 1979 Dec 04; 2(5):329-39. PubMed ID: 492209 [Abstract] [Full Text] [Related]
6. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in female relatives and patients with X-linked muscular dystrophies (Duchenne and Becker). Zatz M, Shapiro LJ, Campion DS, Kaback MM, Otto PA. J Neurol Sci; 1980 Jun 04; 46(3):267-79. PubMed ID: 7381516 [Abstract] [Full Text] [Related]
7. Plasma pyruvate kinase and creatine kinase activity in Becker muscular dystrophy. Aston JP, Kingston HM, Ramasamy I, Walters EG, Stansbie D. J Neurol Sci; 1984 Sep 04; 65(3):307-14. PubMed ID: 6491692 [Abstract] [Full Text] [Related]
11. Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophies. Zatz M, Shapiro LJ, Campion DS, Oda E, Kaback MM. J Neurol Sci; 1978 May 04; 36(3):349-62. PubMed ID: 681967 [Abstract] [Full Text] [Related]
12. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection. Passos MR, Gonzalez CH, Zatz M. Am J Med Genet; 1985 Oct 04; 22(2):255-62. PubMed ID: 4050856 [Abstract] [Full Text] [Related]
14. Creatine-kinase (CK) and pyruvate-kinase (PK) activities in cord blood of normal newborn infants: application to Duchenne muscular dystrophy screening programs. Passos MR, Zatz M. Am J Med Genet; 1983 Nov 04; 16(3):367-72. PubMed ID: 6650572 [Abstract] [Full Text] [Related]
17. [Differential diagnosis of Becker and Duchenne muscular dystrophy]. Alvarez Leal M, Hernández Sifuentes PM, Pérez-Zuno JA. Gac Med Mex; 1994 Nov 04; 130(6):454-8. PubMed ID: 7557060 [Abstract] [Full Text] [Related]
18. Investigation on genetic heterogeneity in Duchenne muscular dystrophy. Rabbi-Bortolini E, Zatz M. Am J Med Genet; 1986 May 04; 24(1):111-7. PubMed ID: 3706399 [Abstract] [Full Text] [Related]
20. Regularity in the change of serum creatine kinase level in Duchenne muscular dystrophy. A study with long-term follow-up cases. Konagaya M, Takayanagi T. Jpn J Med; 1986 Feb 04; 25(1):2-8. PubMed ID: 3712859 [Abstract] [Full Text] [Related] Page: [Next] [New Search]